The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
Controversial plans for a sand and gravel quarry in a Lancashire village have been refused planning permission. At a meeting ...
BASF finds buyer for coatings business; Ineos makes further cuts in Europe; biotechs Soufflé, Nilo, and Expedition launch, ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 ...
Market Overview. The global industrial gases market is experiencing substantial growth, driven by expanding manufacturing ...
Healthtech startup Qure.ai plans to partner with 10,000 hospitals over the next few years to expand use of its AI-based ...
StockStory.org on MSN
2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions ...
Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.
AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...
It was a Super Bowl commercial with a story, and one that sprouted from a real potato grower in Wisconsin. Frito Lay and PepsiCo helped put the spotlight on agriculture Super Bowl Sunday, while also ...
Asia’s poultry sector teetered on the brink of collapse some two decades ago, as bird flu ravaged farms and even posed a threat to human health. At the time, the disease had already infected poultry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results